BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$82.44 USD
-1.36 (-1.62%)
Updated May 3, 2024 04:00 PM ET
After-Market: $82.46 +0.02 (0.02%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2024
Time: -- |
6/2024 | $0.57 | -2.92% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.60 per share. This reflects a positive earnings surprise of 18.33%. Look out for BMRN's next earnings release expected on July 29, 2024. For the next earning release, we expect the company to report earnings of $0.57 per share, reflecting a year-over-year increase of 5.56%.
Earnings History
Price & Consensus
Zacks News for BMRN
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services